Both in Biotechnology
Pelthos Therapeutics vs Caribou Biosciences
Over the past year PTHS returned −70.4% and CRBU returned −81.6%; their daily moves had a correlation of 0.17.
PTHS −70.4% CRBU −81.6%Growth of $1, one year, split-adjusted
| Metric | PTHS | CRBU |
|---|---|---|
| Price | $10.14 | $0.4473 |
| Market cap | $39.9M | $48.0M |
| Today | −5.94% | −2.63% |
| 1 month | −52.8% | −60.6% |
| 6 months | −59.4% | −77.1% |
| Year to date | −67.3% | −71.9% |
| 1 year | — | −81.6% |
| Revenue growth (YoY) | — | −43.8% |
| Gross margin | 76.9% | 100.0% |
| Net margin | −150.1% | −1619.9% |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | 4.8× |
| Net cash | -$45.7M | $112.3M |
| Dividend yield | — | — |
| Volatility (60d) | 140.7% | 146.2% |
| Short % of float | 8.6% | 13.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).